Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis

Kuykendall, AT; Horvat, NP; Pandey, G; Komrokji, R; Reuther, GW

Kuykendall, AT (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA.

CANCERS, 2020; 12 (8):

Abstract

Myelofibrosis (MF) is a myeloproliferative neoplasm hallmarked by the upregulation of the Janus kinase (JAK)-signal transducer and activator of transc......

Full Text Link